Establishment of a novel gene panel as a biomarker of immune checkpoint inhibitor response

OBJECTIVE: Immune checkpoint inhibitors (ICIs) have become the standard of care in various cancers, although the predictive tool is still unknown. METHODS: This study aimed to develop a novel gene panel by selecting DNA damage response (DDR) genes from the Catalogue of Somatic Mutations in Cancer (C...

Descripción completa

Detalles Bibliográficos
Autores principales: Pan, Yi‐Ru, Wu, Chiao‐En, Wang, Yu‐Chao, Yeh, Yi‐Chen, Lu, Meng‐Lun, Hung, Yi‐Ping, Chao, Yee, Yeh, Da‐Wei, Lin, Chien‐Hsing, Hsieh, Jason Chia‐Hsun, Chen, Ming‐Huang, Yeh, Chun‐Nan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2020
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326616/
https://www.ncbi.nlm.nih.gov/pubmed/32617161
http://dx.doi.org/10.1002/cti2.1145

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7326616/
https://www.ncbi.nlm.nih.gov/pubmed/32617161
http://dx.doi.org/10.1002/cti2.1145

Ejemplares similares